Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

SNYR vs PRGO vs PBH vs CLAR vs CHD

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
SNYR
Synergy CHC Corp.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$4M
5Y Perf.-73.1%
PRGO
Perrigo Company plc

Drug Manufacturers - Specialty & Generic

HealthcareNYSE • IE
Market Cap$1.61B
5Y Perf.-78.6%
PBH
Prestige Consumer Healthcare Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$2.58B
5Y Perf.+29.4%
CLAR
Clarus Corporation

Leisure

Consumer CyclicalNASDAQ • US
Market Cap$111M
5Y Perf.-72.4%
CHD
Church & Dwight Co., Inc.

Household & Personal Products

Consumer DefensiveNYSE • US
Market Cap$22.24B
5Y Perf.+25.1%

SNYR vs PRGO vs PBH vs CLAR vs CHD — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
SNYR logoSNYR
PRGO logoPRGO
PBH logoPBH
CLAR logoCLAR
CHD logoCHD
IndustryMedical - DistributionDrug Manufacturers - Specialty & GenericMedical - DistributionLeisureHousehold & Personal Products
Market Cap$4M$1.61B$2.58B$111M$22.24B
Revenue (TTM)$35M$4.18B$1.10B$254M$6.21B
Net Income (TTM)$3M$-1.82B$187M$-45M$733M
Gross Margin71.0%34.2%56.4%29.2%45.1%
Operating Margin18.0%-4.1%29.2%-7.9%17.3%
Forward P/E1.4x5.6x12.0x25.0x
Total Debt$28M$3.97B$1.04B$12M$2.21B
Cash & Equiv.$688K$532M$98M$37M$409M

SNYR vs PRGO vs PBH vs CLAR vs CHDLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

SNYR
PRGO
PBH
CLAR
CHD
StockMay 20May 26Return
Synergy CHC Corp. (SNYR)10026.9-73.1%
Perrigo Company plc (PRGO)10021.4-78.6%
Prestige Consumer H… (PBH)100129.4+29.4%
Clarus Corporation (CLAR)10027.6-72.4%
Church & Dwight Co.… (CHD)100125.1+25.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: SNYR vs PRGO vs PBH vs CLAR vs CHD

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CHD leads in 3 of 7 categories (5-stock set), making it the strongest pick for growth and revenue expansion and capital preservation and lower volatility. Synergy CHC Corp. is the stronger pick specifically for valuation and capital efficiency and operational efficiency and capital deployment. PRGO and PBH also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
SNYR
Synergy CHC Corp.
The Value Play

SNYR is the #2 pick in this set and the best alternative if value and efficiency is your priority.

  • Lower P/E (1.4x vs 25.0x)
  • 12.5% ROA vs CLAR's -21.6%, ROIC 88.1% vs -8.2%
Best for: value and efficiency
PRGO
Perrigo Company plc
The Income Pick

PRGO ranks third and is worth considering specifically for income & stability and defensive.

  • Dividend streak 10 yrs, beta 1.18, yield 9.8%
  • Beta 1.18, yield 9.8%, current ratio 2.76x
  • 9.8% yield, 10-year raise streak, vs CHD's 1.3%, (2 stocks pay no dividend)
Best for: income & stability and defensive
PBH
Prestige Consumer Healthcare Inc.
The Quality Compounder

PBH is the clearest fit if your priority is quality.

  • 16.9% margin vs PRGO's -43.5%
Best for: quality
CLAR
Clarus Corporation
The Income Angle

Among these 5 stocks, CLAR doesn't own a clear edge in any measured category.

Best for: consumer cyclical exposure
CHD
Church & Dwight Co., Inc.
The Growth Play

CHD carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
  • 113.6% 10Y total return vs PBH's -3.7%
  • Lower volatility, beta 0.14, Low D/E 55.1%, current ratio 1.07x
  • 1.6% revenue growth vs SNYR's -18.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthCHD logoCHD1.6% revenue growth vs SNYR's -18.6%
ValueSNYR logoSNYRLower P/E (1.4x vs 25.0x)
Quality / MarginsPBH logoPBH16.9% margin vs PRGO's -43.5%
Stability / SafetyCHD logoCHDBeta 0.14 vs CLAR's 1.34
DividendsPRGO logoPRGO9.8% yield, 10-year raise streak, vs CHD's 1.3%, (2 stocks pay no dividend)
Momentum (1Y)CHD logoCHD+3.4% vs SNYR's -78.8%
Efficiency (ROA)SNYR logoSNYR12.5% ROA vs CLAR's -21.6%, ROIC 88.1% vs -8.2%

SNYR vs PRGO vs PBH vs CLAR vs CHD — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

SNYRSynergy CHC Corp.
FY 2024
Retail
100.0%$26M
PRGOPerrigo Company plc
FY 2025
Consumer Self-Care Americas
60.8%$2.6B
Consumer Self-Care International
39.2%$1.7B
PBHPrestige Consumer Healthcare Inc.
FY 2025
Gastrointestinal
22.5%$256M
Women's Health
20.8%$237M
Eye and Ear Care
16.1%$183M
Dermatologicals
11.3%$129M
Analgesics
10.3%$118M
Cough and Cold
9.3%$106M
Oral Care
8.4%$95M
Other (1)
1.2%$14M
CLARClarus Corporation
FY 2025
Outdoor Segment
70.6%$177M
Adventure Segment
29.4%$74M
CHDChurch & Dwight Co., Inc.
FY 2025
Specialty Products Division
100.0%$299M

SNYR vs PRGO vs PBH vs CLAR vs CHD — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCHDLAGGINGCLAR

Income & Cash Flow (Last 12 Months)

PBH leads this category, winning 3 of 6 comparable metrics.

CHD is the larger business by revenue, generating $6.2B annually — 179.4x SNYR's $35M. PBH is the more profitable business, keeping 16.9% of every revenue dollar as net income compared to PRGO's -43.5%. On growth, SNYR holds the edge at +12.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricSNYR logoSNYRSynergy CHC Corp.PRGO logoPRGOPerrigo Company p…PBH logoPBHPrestige Consumer…CLAR logoCLARClarus CorporationCHD logoCHDChurch & Dwight C…
RevenueTrailing 12 months$35M$4.2B$1.1B$254M$6.2B
EBITDAEarnings before interest/tax$6M$58M$353M-$11M$1.3B
Net IncomeAfter-tax profit$3M-$1.8B$187M-$45M$733M
Free Cash FlowCash after capex-$7M$108M$267M-$12M$1.1B
Gross MarginGross profit ÷ Revenue+71.0%+34.2%+56.4%+29.2%+45.1%
Operating MarginEBIT ÷ Revenue+18.0%-4.1%+29.2%-7.9%+17.3%
Net MarginNet income ÷ Revenue+7.5%-43.5%+16.9%-17.6%+11.8%
FCF MarginFCF ÷ Revenue-19.2%+2.6%+24.2%-4.9%+17.2%
Rev. Growth (YoY)Latest quarter vs prior year+12.4%-7.2%-2.4%+2.5%+0.1%
EPS Growth (YoY)Latest quarter vs prior year-87.6%-56.4%-20.5%+35.7%+2.2%
PBH leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

Evenly matched — SNYR and PRGO each lead in 2 of 6 comparable metrics.

At 1.4x trailing earnings, SNYR trades at a 95% valuation discount to CHD's 31.1x P/E. On an enterprise value basis, SNYR's 5.3x EV/EBITDA is more attractive than CHD's 18.1x.

MetricSNYR logoSNYRSynergy CHC Corp.PRGO logoPRGOPerrigo Company p…PBH logoPBHPrestige Consumer…CLAR logoCLARClarus CorporationCHD logoCHDChurch & Dwight C…
Market CapShares × price$4M$1.6B$2.6B$111M$22.2B
Enterprise ValueMkt cap + debt − cash$31M$5.1B$3.5B$87M$24.0B
Trailing P/EPrice ÷ TTM EPS1.41x-1.14x12.72x-2.39x31.09x
Forward P/EPrice ÷ next-FY EPS est.5.56x12.02x25.01x
PEG RatioP/E ÷ EPS growth rate1.40x
EV / EBITDAEnterprise value multiple5.27x7.42x9.62x18.14x
Price / SalesMarket cap ÷ Revenue0.13x0.38x2.27x0.44x3.59x
Price / BookPrice ÷ Book value/share0.55x1.49x0.56x5.73x
Price / FCFMarket cap ÷ FCF11.12x10.62x20.35x
Evenly matched — SNYR and PRGO each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

Evenly matched — CLAR and CHD each lead in 3 of 9 comparable metrics.

CHD delivers a 17.4% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-51 for PRGO. CLAR carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to PRGO's 1.35x. On the Piotroski fundamental quality scale (0–9), PBH scores 8/9 vs CLAR's 2/9, reflecting strong financial health.

MetricSNYR logoSNYRSynergy CHC Corp.PRGO logoPRGOPerrigo Company p…PBH logoPBHPrestige Consumer…CLAR logoCLARClarus CorporationCHD logoCHDChurch & Dwight C…
ROE (TTM)Return on equity-50.7%+10.2%-21.2%+17.4%
ROA (TTM)Return on assets+12.5%-19.8%+5.3%-21.6%+8.2%
ROICReturn on invested capital+88.1%+3.7%+9.1%-8.2%+13.9%
ROCEReturn on capital employed+4.3%+10.4%-17.9%+14.4%
Piotroski ScoreFundamental quality 0–944827
Debt / EquityFinancial leverage1.35x0.57x0.06x0.55x
Net DebtTotal debt minus cash$27M$3.4B$946M-$24M$1.8B
Cash & Equiv.Liquid assets$687,920$532M$98M$37M$409M
Total DebtShort + long-term debt$28M$4.0B$1.0B$12M$2.2B
Interest CoverageEBIT ÷ Interest expense1.46x-7.20x7.40x15.59x
Evenly matched — CLAR and CHD each lead in 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CHD leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in PBH five years ago would be worth $11,842 today (with dividends reinvested), compared to $1,719 for CLAR. Over the past 12 months, CHD leads with a +3.4% total return vs SNYR's -78.8%. The 3-year compound annual growth rate (CAGR) favors SNYR at 10.0% vs CLAR's -27.8% — a key indicator of consistent wealth creation.

MetricSNYR logoSNYRSynergy CHC Corp.PRGO logoPRGOPerrigo Company p…PBH logoPBHPrestige Consumer…CLAR logoCLARClarus CorporationCHD logoCHDChurch & Dwight C…
YTD ReturnYear-to-date-79.0%-13.5%-10.8%-13.2%+14.0%
1-Year ReturnPast 12 months-78.8%-51.2%-32.9%-12.3%+3.4%
3-Year ReturnCumulative with dividends+33.0%-58.1%-8.3%-62.4%+0.7%
5-Year ReturnCumulative with dividends+10.4%-60.1%+18.4%-82.8%+13.7%
10-Year ReturnCumulative with dividends-94.7%-77.7%-3.7%-13.5%+113.6%
CAGR (3Y)Annualised 3-year return+10.0%-25.2%-2.8%-27.8%+0.2%
CHD leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

CHD leads this category, winning 2 of 2 comparable metrics.

CHD is the less volatile stock with a 0.14 beta — it tends to amplify market swings less than CLAR's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.5% from its 52-week high vs SNYR's 9.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricSNYR logoSNYRSynergy CHC Corp.PRGO logoPRGOPerrigo Company p…PBH logoPBHPrestige Consumer…CLAR logoCLARClarus CorporationCHD logoCHDChurch & Dwight C…
Beta (5Y)Sensitivity to S&P 5000.79x1.18x0.53x1.34x0.14x
52-Week HighHighest price in past year$4.00$28.44$89.37$4.03$106.04
52-Week LowLowest price in past year$0.30$9.23$51.24$2.58$81.33
% of 52W HighCurrent price vs 52-week peak+9.9%+41.2%+61.1%+71.7%+88.5%
RSI (14)Momentum oscillator 0–10023.060.936.458.549.1
Avg Volume (50D)Average daily shares traded1.3M3.4M478K217K1.8M
CHD leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — PRGO and CHD each lead in 1 of 2 comparable metrics.

Analyst consensus: PRGO as "Hold", PBH as "Buy", CLAR as "Hold", CHD as "Buy". Consensus price targets imply 73.0% upside for CLAR (target: $5) vs 6.1% for CHD (target: $100). For income investors, PRGO offers the higher dividend yield at 9.81% vs CHD's 1.25%.

MetricSNYR logoSNYRSynergy CHC Corp.PRGO logoPRGOPerrigo Company p…PBH logoPBHPrestige Consumer…CLAR logoCLARClarus CorporationCHD logoCHDChurch & Dwight C…
Analyst RatingConsensus buy/hold/sellHoldBuyHoldBuy
Price TargetConsensus 12-month target$20.00$66.00$5.00$99.60
# AnalystsCovering analysts36171134
Dividend YieldAnnual dividend ÷ price+9.8%+3.5%+1.3%
Dividend StreakConsecutive years of raises110123
Dividend / ShareAnnual DPS$1.15$0.10$1.18
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+2.0%+0.0%+4.0%
Evenly matched — PRGO and CHD each lead in 1 of 2 comparable metrics.
Key Takeaway

CHD leads in 2 of 6 categories (Total Returns, Risk & Volatility). PBH leads in 1 (Income & Cash Flow). 3 tied.

Best OverallChurch & Dwight Co., Inc. (CHD)Leads 2 of 6 categories
Loading custom metrics...

SNYR vs PRGO vs PBH vs CLAR vs CHD: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is SNYR or PRGO or PBH or CLAR or CHD a better buy right now?

For growth investors, Church & Dwight Co.

, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus -18. 6% for Synergy CHC Corp. (SNYR). Synergy CHC Corp. (SNYR) offers the better valuation at 1. 4x trailing P/E, making it the more compelling value choice. Analysts rate Prestige Consumer Healthcare Inc. (PBH) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — SNYR or PRGO or PBH or CLAR or CHD?

On trailing P/E, Synergy CHC Corp.

(SNYR) is the cheapest at 1. 4x versus Church & Dwight Co. , Inc. at 31. 1x. On forward P/E, Perrigo Company plc is actually cheaper at 5. 6x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — SNYR or PRGO or PBH or CLAR or CHD?

Over the past 5 years, Prestige Consumer Healthcare Inc.

(PBH) delivered a total return of +18. 4%, compared to -82. 8% for Clarus Corporation (CLAR). Over 10 years, the gap is even starker: CHD returned +113. 6% versus SNYR's -94. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — SNYR or PRGO or PBH or CLAR or CHD?

By beta (market sensitivity over 5 years), Church & Dwight Co.

, Inc. (CHD) is the lower-risk stock at 0. 14β versus Clarus Corporation's 1. 34β — meaning CLAR is approximately 865% more volatile than CHD relative to the S&P 500. On balance sheet safety, Clarus Corporation (CLAR) carries a lower debt/equity ratio of 6% versus 135% for Perrigo Company plc — giving it more financial flexibility in a downturn.

05

Which is growing faster — SNYR or PRGO or PBH or CLAR or CHD?

By revenue growth (latest reported year), Church & Dwight Co.

, Inc. (CHD) is pulling ahead at 1. 6% versus -18. 6% for Synergy CHC Corp. (SNYR). On earnings-per-share growth, the picture is similar: Synergy CHC Corp. grew EPS 297. 2% year-over-year, compared to -723. 2% for Perrigo Company plc. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — SNYR or PRGO or PBH or CLAR or CHD?

Prestige Consumer Healthcare Inc.

(PBH) is the more profitable company, earning 18. 9% net margin versus -33. 5% for Perrigo Company plc — meaning it keeps 18. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PBH leads at 29. 6% versus -8. 2% for CLAR. At the gross margin level — before operating expenses — SNYR leads at 67. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is SNYR or PRGO or PBH or CLAR or CHD more undervalued right now?

On forward earnings alone, Perrigo Company plc (PRGO) trades at 5.

6x forward P/E versus 25. 0x for Church & Dwight Co. , Inc. — 19. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CLAR: 73. 0% to $5. 00.

08

Which pays a better dividend — SNYR or PRGO or PBH or CLAR or CHD?

In this comparison, PRGO (9.

8% yield), CLAR (3. 5% yield), CHD (1. 3% yield) pay a dividend. SNYR, PBH do not pay a meaningful dividend and should not be held primarily for income.

09

Is SNYR or PRGO or PBH or CLAR or CHD better for a retirement portfolio?

For long-horizon retirement investors, Church & Dwight Co.

, Inc. (CHD) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 14), 1. 3% yield, +113. 6% 10Y return). Both have compounded well over 10 years (CHD: +113. 6%, SNYR: -94. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between SNYR and PRGO and PBH and CLAR and CHD?

These companies operate in different sectors (SNYR (Healthcare) and PRGO (Healthcare) and PBH (Healthcare) and CLAR (Consumer Cyclical) and CHD (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SNYR is a small-cap deep-value stock; PRGO is a small-cap income-oriented stock; PBH is a small-cap deep-value stock; CLAR is a small-cap income-oriented stock; CHD is a mid-cap quality compounder stock. PRGO, CLAR, CHD pay a dividend while SNYR, PBH do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

SNYR

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 5%
Run This Screen
Stocks Like

PRGO

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 20%
  • Dividend Yield > 3.9%
Run This Screen
Stocks Like

PBH

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 10%
Run This Screen
Stocks Like

CLAR

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Gross Margin > 17%
  • Dividend Yield > 1.3%
Run This Screen
Stocks Like

CHD

Stable Dividend Mega-Cap

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Net Margin > 7%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform SNYR and PRGO and PBH and CLAR and CHD on the metrics below

Revenue Growth>
%
(SNYR: 12.4% · PRGO: -7.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.